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ABSTRACT 
 
BACKGROUND 
 
HIV infection is common in South Africa. The disease often remains clinically 
latent, despite the patient having severe immune compromise. Clinical 
preoperative assessment may result in patients with this severe systemic disease 
going unnoticed.  
 
OBJECTIVES 
 
The primary objective was to determine the relationship between the preoperative 
physical status of HIV-positive patients presenting for anaesthesia and the CD4-
count. The secondary objectives were to determine the prevalence of HIV 
infection in this group of patients, to determine the prevalence of HIV infection in 
selected subgroups, to ascertain what proportion of patients presenting for 
anaesthesia know their HIV status, and to ascertain what proportion of HIV-
positive patients are receiving highly active antiretroviral therapy (HAART). 
 
METHOD 
 
A sample of 350 adult patients presenting for anaesthesia at Chris Hani 
Baragwanath Hospital was selected. Patients were interviewed preoperatively 
and were examined, and in doing so their ASA physical status grading was 
determined. Blood was sampled, and in those who were confirmed HIV-positive, 
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a CD4-count was checked. Further data were collected: age, gender, the type, 
nature, urgency and time of day of surgery, the patient’s knowledge of their HIV 
status, and whether the patient was receiving HAART or not. 
 
RESULTS 
 
HIV-positive patients were more likely to be classified as ASA 1 or 2 than ASA 3 
or 4 (OR 2.1). HIV-positive patients with CD4-counts above 200 cells.mm-3 were 
also more likely to be ASA 1 or 2 than ASA 3 or 4 (OR 3.88). However, within the 
group of HIV-positive patients with CD4-counts below 200 cells.mm-3, significantly 
more patients were classified as ASA 1 or 2 than ASA 3 or 4 (p<0.0001). Three 
patients with CD4-counts below 50 cells.mm-3 were classified as ASA 1 or 2. The 
overall prevalence of HIV infection was 29.4%. Within the various subgroups, the 
groups with higher disease prevalence rates were females, patients presenting 
for obstetric surgery, and the younger age groups. The highest prevalence of HIV 
infection was found in patients aged 30-39 years (43.0%), and the lowest 
prevalence was found in patients aged 60 years or older (7.7%).  
 
CONCLUSIONS 
 
Routine clinical preoperative assessment in patients from a population with a high 
HIV prevalence rate may result in asymptomatic, severe immune compromise 
secondary to HIV infection being missed in a significant number of patients. 
Further study into the perioperative outcomes of these patients is warranted. 
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CHAPTER ONE – INTRODUCTION 
 
Countries in Sub-Saharan Africa carry the highest prevalence of HIV infection 
worldwide, with a rate of 7.2%, and South Africa ranks highly within this group1.  
 
Patients are assessed preoperatively in order to determine their physical fitness, 
for both the planned surgery and the planned anaesthetic. Anaesthetists will take 
a history from the patient and examine them clinically. These findings are often 
summarised in a more objective format, such as a grading according to the 
American Society of Anesthesiologists (ASA) physical status grading system, 
which is a score from 1-5 and denotes risk of perioperative mortality. Following 
this, anaesthetists will order appropriate investigations in order to ascertain the 
level of risk associated with proceeding with surgery, and to guide any 
preoperative optimisation of function that may be required2.  
 
HIV infection remains clinically latent for a variable length of time. An infected 
individual may only present with signs or symptoms once they are already 
severely immune compromised, and may appear clinically ‘normal’ despite 
marked levels of immune suppression3. As a result, there is a concern that a 
patient who is clinically well on physical examination, with no features which may 
prompt further investigation, may in fact be HIV-positive with a significant level of 
immune compromise. The implications of this are still unclear, as few studies 
have focussed on this subgroup of patients in the perioperative period. 
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According to the available literature reviewed, no similar study has been 
published.  
 
1.1   Problem statement 
 
HIV-positive patients presenting for anaesthesia at Chris Hani Baragwanath 
Hospital (CHBH) may be classified preoperatively as being clinically well, despite 
being markedly immune compromised. 
  
1.2   Aim 
 
The aim of this study is to investigate whether the preoperative clinical condition, 
as indicated by the ASA physical status grading, of a patient presenting for 
anaesthesia at CHBH correlates with subsequent laboratory testing for HIV 
infection and level of immune compromise, as denoted by the CD4-count. 
 
1.3   Objectives 
 
1.3.1    Primary objective: 
To determine the association between the ASA physical status grading of 
 HIV-positive patients presenting for anaesthesia and the CD4-count of 
 those  patients. 
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1.3.2   Secondary objectives: 
(a) To determine the prevalence of HIV in the patient sample. 
(b) To determine and compare the prevalence of HIV in the following  
  subgroups of patients: 
• different age groups 
• male and female patients 
• patients presenting for obstetric and non-obstetric surgery  
• patients presenting for elective and emergency surgery  
• patients presenting for clean and septic procedures 
(c) To determine how many patients presenting for anaesthesia are 
aware of their HIV status. 
(d) To determine how many patients presenting for anaesthesia are 
receiving highly active antiretroviral therapy (HAART). 
 
1.4   Research assumptions 
 
1.4.1 Definitions: 
 
The following definitions were used in this study: 
 
Type of surgery: the category of surgery for which the patient is   
 presenting. 
• Obstetric surgery: any procedure relating to a pregnancy, for 
example caesarean section, uterine evacuation, laparotomy for 
ectopic pregnancy. 
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• Non-obstetric surgery: any procedure not relating to pregnancy. All 
other surgical disciplines are included in this group, for example 
maxillofacial surgery, urological surgery, neurosurgery and 
orthopaedic surgery. 
 
Urgency of surgery: denotes how much time the anaesthetist had for the 
 preoperative assessment. 
• Elective surgery: a procedure that was booked on the day prior to 
surgery, allowing the anaesthetist sufficient time for full preoperative 
assessment and patient optimisation, for example total hip 
replacement, mastectomy, repair of an uncomplicated hernia. 
• Emergency surgery: a procedure that was booked on the same day 
as surgery, not allowing the anaesthetist sufficient time for full 
preoperative assessment and optimisation, for example 
appendicectomy for acute appendicitis, exploratory laparotomy for 
blunt abdominal trauma, caesarean section for foetal distress. 
 
Nature of surgery: denotes the level of contamination associated with the 
 surgery. 
• Clean surgery: procedures associated with minimal levels of 
contamination, for example open reduction and internal fixation of a 
fractured ankle, laparoscopic cholecystectomy, uterine evacuation 
for retained products of conception. 
• Septic surgery: procedures associated with significant levels of 
contamination, for example incision and drainage of a Bartholin’s 
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abscess, debridement of an infected diabetic foot, frontal 
ethmoidectomy for severe sinusitis. 
 
Time of day of surgery: denotes during which shift the procedure was 
 booked for. 
• Office hours: procedures booked to be done from Monday-Friday 
during the time period from 08h00-16h00. 
• After hours: procedures booked to be done when only emergency 
anaesthesia staff are present, namely from Monday to Thursday 
from 16h00 until 08h00 the next morning, and from 16h00 on a 
Friday until 08h00 on a Monday morning. 
 
1.5   Study design 
 
This is a prospective cross-sectional relational observational study.  
 
1.6   Ethical considerations 
 
1.6.1 Ethical clearance: 
The study has been approved by the regional Ethics Committee – the 
Committee for Research on Human Subjects (Medical) of the University of 
the Witwatersrand (Appendix A). 
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1.6.2 Post-Graduate approval: 
The study has been approved by the Post-Graduate Committee of the 
University of the Witwatersrand, Faculty of Health Sciences (Appendix B).  
1.6.3 Site approval: 
Permission has been granted by the Superintendent of Chris Hani 
Baragwanath Hospital (Appendix C). 
 
1.6.4 Patient approval: 
Patients were invited to participate in the study. Patients received a printed 
document (Appendix D) explaining the reason for the study, exactly what 
their involvement in the study would be, their right to refuse to participate 
without any repercussions on their care, and their right to withdraw from 
the study at any time. A 24-hour contact number was supplied should they 
have required further information. The printed information was provided in 
English. The researcher and a translator provided verbal information in a 
language that the patient could understand if they couldn’t understand 
English, or were not able to read the document. Written consent was 
obtained from all patients agreeing to participate (Appendix E). The 
counselling form (Appendix F) was signed as confirmation that the 
patients had received appropriate pre-test counselling. 
 
1.6.5 Declaration of Helsinki: 
The research was conducted according to the principles described in the 
Declaration of Helsinki4. 
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1.7   Summary of methodology 
 
A sample of 350 adult patients was selected using modified consecutive 
sampling. A trained counsellor gave pre-test counselling, and informed consent 
was obtained.  
 
All patients were interviewed and examined by the principal investigator. The ASA 
physical status grading was determined. Secondary data were recorded 
regarding their age group, gender and ASA physical status grading, as well as the 
type of surgery they had been booked for, the urgency of the procedure and the 
nature of the surgery.  The knowledge of HIV status was also recorded, and 
whether they were receiving HAART or not. 
 
Patients who did not know their HIV status had blood sampled for HIV testing and 
CD4-count. Patients who were known to be HIV-positive had blood sampled for 
CD4-count only. The blood samples were sent for Rapid HIV Antibody testing. 
Those samples that tested positive were sent for confirmatory HIV ELISA testing, 
and the results were recorded. The samples for CD4-count were only sent for 
testing in those patients whose status was confirmed to be HIV-positive.  
 
The patients were given their test results postoperatively with appropriate post-
test counselling, unless they had chosen not to receive them. Patients that had 
tested HIV-positive were referred to the Department of Infectious Diseases for 
ongoing management of their condition, including ongoing counselling. The 
patients were not followed up postoperatively. 
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The data was analysed using Stata statistical software package. The association 
between the ASA physical status grading and HIV status as well as CD4-count (in 
those patients that tested HIV-positive) was described. Logistic regression 
analysis and the Mantel-Haenszel combined odds ratio were used to adjust for 
the presence of confounding variables. The prevalence of HIV infection was 
determined in the total sample as well as in the various subgroups, and these 
were compared using the chi-squared test, Fisher’s exact test or the continuity 
correction. The knowledge of HIV status was recorded and described, as was the 
use of HAART. 
 
1.8   Significance of study 
 
A positive relationship between the preoperative physical status of HIV-positive 
patients and their degree of immune compromise will indicate that clinical 
examination of patients preoperatively is a sufficient means of detecting the 
presence of immune compromise. It will indicate that the severity of HIV-infection 
can be clinically assessed in patients who present for anaesthesia and have not 
tested for HIV, or who have tested HIV-positive but have not been assessed with 
regard to their level of immunity. 
 
However, if there is no relationship between the preoperative physical status of 
HIV-positive patients and their degree of immune compromise, this will indicate 
that clinical examination is an insufficient means of assessing HIV-positive 
patients. Patients with severe immune compromise may be assessed as clinically 
normal. The current practice is that patients who are assessed as clinically 
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normal are not investigated further unless there are questions raised by their 
history. Patients who are unaware of their HIV status will not be suspected of 
having impaired immunity, and will therefore present for anaesthesia and surgery 
without having their degree of immune compromise determined. The implications 
of this remain unclear, although available literature provides some speculation as 
to the negative impact that this may have on patient outcome. If this is so, the 
results of this study may encourage the formation of new policies regarding the 
preoperative assessment of patients, which may include more widespread testing 
of patients for HIV infection, as well as determining the level of immune function 
in HIV-positive patients. This knowledge will allow for the appropriate 
management strategy to be selected for the care of the patient. 
 
Determining the prevalence of HIV infection in the population of patients 
presenting for anaesthesia will allow anaesthetists to be aware of the magnitude 
of the HIV burden in the patients they manage. If the prevalence is high, then the 
management of this subgroup of patients can be prioritised. This will help to 
improve the quality of care that these patients receive, and will improve patient 
safety. This may also encourage improvements to be developed in ensuring the 
safety of operating theatre staff. This may also direct further research into this 
subgroup of patients. 
 
Determining how many patients are aware of their HIV status will allow 
anaesthetists to realise how many patients will be able to give an accurate history 
that will arouse suspicion of underlying immune compromise. If the majority of 
patients are aware of their HIV status, the potential need for more widespread 
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preoperative HIV testing will be less than if very few patients know their HIV 
status. 
 
Determining how many HIV-positive patients presenting for anaesthesia are 
receiving HAART will allow anaesthetists to ascertain how many patients are 
accessing appropriate healthcare for their condition. These patients would be 
regularly having their level of immunity assessed and managed. If this applies to 
most HIV-positive patients, then the potential need for perioperative investigation 
into the degree of immune compromise will be less than if most HIV-positive 
patients are unaware of their level of immunity.  
 
1.9   Limitations of study 
 
1.9.1 Study period: 
The data collection was done over a six-week period in December and 
 January. Some elective lists are closed for one or two weeks during this 
 period. The patients presenting during this time could have been 
 scheduled for more emergent procedures than at other times of the year.  
 
1.9.2 Patient categorisation: 
Patients were categorised on the basis of the type of operating theatre in 
 which  they were booked, whether clean or contaminated, elective or 
 emergent. Occasionally, cases that are inappropriate for that type of 
 operating theatre are still booked to be done in them.  
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1.9.3 Quality of data collection: 
This was a single observer study. Only the researcher was involved in the 
 categorisation of patients, in order to minimise the subjectivity inherent in 
 the ASA physical status grading. The researcher may have been stricter or 
 more lenient in grading patients than other anaesthetists.  
Data was captured using double entries, and the complete data set was 
 checked by a biostatistician.  
 
1.9.4 Contextuality: 
This study was done in the context of patients presenting for anaesthesia 
at CHBH. Generalisation to other populations may be limited. 
 
1.10 Research report outline 
 
This research report will comprise the following chapters: 
 
Chapter One – the introduction to the study, including the aim and objectives of  
 the study, and a brief summary of the methodology used. 
Chapter Two – a review of the literature pertinent to topics raised by the study. 
Chapter Three – an in-depth description of the methodology used for the study. 
Chapter Four – the results of the study. 
Chapter Five – an interpretation of the results of the study, and a discussion of 
 the questions and answers raised by the results. 
Chapter Six – a summary of the study, and conclusions drawn from the study. 
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CHAPTER TWO – LITERATURE REVIEW 
 
2.1 History and epidemiology of the HIV/AIDS pandemic 
 
2.1.1 The global scenario 
 
The history of the Human Immunodeficiency Virus/Acquired Immune Deficiency 
Syndrome (HIV/AIDS) pandemic began in 1981 with the isolation of the virus and 
its causal link to the syndrome5. Prior to this, the commonest features of the 
syndrome were grouped under a variety of terms, for example slim disease6 or 
idiopathic lymphadenopathy syndrome7. The aetiological virus was named either 
human T-cell lymphotropic virus type III (HTLV-III), lymphadenopathy-associated 
virus (LAV) or AIDS-associated retrovirus (ARV)7. Following this discovery, the 
clinical features as well as the natural history of the HIV infection have undergone 
extensive study and now form a well-defined disease entity8. 
 
The spread of HIV infection is through body fluids, with the three commonest 
routes initially being sexual transmission, transmission through sharing of 
hypodermic needles amongst intravenous drug users and transmission via 
infected blood transfusions8. The high prevalence amongst homosexual men 
resulted in a mistaken assumption that this group were at higher risk for 
transmission, but it is now known that the burden of infection can be even higher 
in heterosexual populations9. With the advent of the pandemic came widespread 
screening of donated blood products, as well as strict criteria for acceptance of 
blood donors10. This has lead to transmission via infected blood products being 
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extremely uncommon, and the spread of the infection into the heterosexual 
population has resulted in mother-to-child-transmission (MTCT), or peripartum, 
infection becoming one of the commonest routes of infection today11.  
 
2.1.2 The South African scenario 
 
The epidemiology of the HIV infection in South Africa is quite different to that in 
developed countries. Historically, the black population was relocated into remote 
parts of the country, forcing a major increase in migrant labour3. Men (and on 
occasion women) moved to work in cities and towns, and could only return to 
their families when on leave. Traditional communities were largely patriarchal, 
and women stayed at home to look after the children. Concurrently, education of 
the black people was substandard. The sex trade flourished as women were 
forced to earn a living, and men were separated from their families for prolonged 
periods of time.  
 
Today, despite changes in government policy and the abolition of apartheid, the 
legacy of this regime remains12 13. Migrant labour and the associated use of the 
sex trade continues (especially in the trucking community14), and while education 
standards have improved, poverty and unemployment are still high15. Access to 
healthcare is often limited16, and may even be discouraged by community 
members who advocate traditional health practices17. Many societies are still 
male-dominant, and empowerment of women to make choices for themselves is 
severely lagging18. An environment is thus created wherein the spread of HIV 
infection amongst heterosexual people continues largely unabated.  
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South Africa carries the dubious honour of having one of the highest prevalence 
rates of HIV infection in the world, with an estimated adult rate of 18.8% (16.8-
20.7)19. HIV is not a notifiable disease, and as such, all statistics have been 
based on estimates and models. Initially, the prevalence rates were based on 
extrapolation of test results of women attending antenatal clinics20. At this stage, 
the prevalence of HIV ranged from 15.4% to 40.7%, depending on the province. 
In 2002, the first national level household survey was undertaken using a random 
sample of males and females aged 2 years and older21. This revealed a total 
prevalence of 11.4%. In 2005, the survey was repeated, this time estimating the 
prevalence at 10.8%22. However, these single-figure numbers are often unhelpful: 
within the samples, the prevalence differed greatly depending on age group, 
geographical area, gender and race – ranging from 0.6% (white people in 2005) 
to 16.5% (people in Kwazulu-Natal province in 2005). This indicates the 
complexities involved in assigning risk of infection to a population group. 
Moreover, an individual has the right to refuse testing23. This results in prevalence 
rates which are skewed and thus potentially inaccurate.  
 
Despite all these issues, what pervades is that the epidemic is large, and also 
present in every part of society in South Africa. It affects mainly heterosexual 
people, although as in developed countries, there is still a contribution to the 
prevalence rate from homosexual male groups and intravenous drug users. The 
infection of children is also high, as can be expected following the obvious 
increase in MTCT8. 
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2.2   Management of HIV infection 
 
2.2.1 Principles of management 
 
Management of HIV infection involves a multidisciplinary approach. With the lack 
of an outright cure or vaccination, attention is focussed on maintaining clinical 
latency, that is, stopping disease progression24. Efforts are made to maintain a 
good state of health and nutrition, and to stop reinfection from other sources. 
Once the disease has progressed to a level wherein the individual is significantly 
immune compromised, pharmacotherapy is considered.  
 
Highly active antiretroviral therapy (HAART) comprises a combination of drugs 
which act at different stages of the viral infective process. The drugs act together 
to suppress viral replication and thereby to lower to viral load, ideally to 
undetectable levels. The South African guidelines stipulate that HAART should be 
started in an infected individual once their CD4-count is below 200 cells.mm-3, or 
if they show severe clinical disease (WHO clinical stage 4, see Table 2.1), 
whichever happens earlier25. This practice has been criticised26 27. It appears that, 
once the CD4-count drops below 350 cells.mm-3 then the decision to start HAART 
should probably be made sooner than it is currently made24 28 29. 
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Table 2.1  World Health Organisation Adults HIV and AIDS Staging   
  System 
 
WHO 
Stage 1 
Seroconversion illness 
Asymptomatic infection 
Persistent generalised lymphadenopathy 
Performance status 1 (fully active and asymptomatic) 
WHO 
Stage 2 
Less than 10% unintentional weight loss 
Herpes zoster within the last 5 years 
Minor mucocutaneous manifestations (eg seborrhoea, prurigo, fungal 
nail infections, oral ulcers, angular cheilitis) 
Recurrent upper respiratory tract infections (eg bacterial sinusitis) 
Performance status 2 (symptomatic but near fully active) 
WHO 
Stage 3 
More than 10% unintentional weight loss 
Chronic diarrhoea for > 1 month 
Prolonged fever for > 1 month 
Oral candida 
Vulvovaginal candidiasis > 1 month with poor response to therapy 
Oral hairy leukoplakia 
Severe bacterial infection (pneumonia, pyomyositis) 
Pulmonary tuberculosis within the last year 
Performance status 3 (bedridden <50% of past month) 
WHO 
Stage 4 
Extrapulmonary tuberculosis 
Pneumocystis jeroveci pneumonia 
Cryptococcal meningitis 
Herpes simplex virus ulcer > 1 month or visceral infection 
Oesophageal or pulmonary candidiasis 
CNS toxoplasmosis 
Cryptosporidiosis plus diarrhoea > 1 month 
Isosporiasis plus diarrhoea > 1 month 
Cytomegalovirus infection other than liver, spleen or lymph node 
HIV wasting syndrome 
HIV encephalopathy (AIDS-dementia complex) 
Kaposi’s sarcoma 
Progressive multifocal leukoencephalopathy 
Disseminated mycosis 
Atypical disseminated mycobacteriosis 
Non-typhoid Salmonella bacteraemia 
Lymphoma 
Recurrent pneumonia 
Invasive cervical carcinoma 
Performance status 4 (confined to bed >50% of past month) 
 
However, for HAART to be effective it requires excellent compliance on the part 
of the patient. Viral resistance results in treatment failure – a problem for both the 
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patient and whoever may be infected by that patient in the future. HAART has 
several severe side-effects, which may even be fatal30 31. Usually three drugs are 
prescribed, resulting in a complicated treatment regimen. Subsequently, the 
decision to start HAART in an individual is not taken lightly, and careful follow-up 
and ongoing counselling is required24.  
 
It has been shown that there is a period in the natural history of the disease 
where HAART has optimal effect29. Early HAART increases the risks of 
developing long-term drug toxicity and viral resistance. This means that when the 
patient becomes symptomatic, the options available for treatment are fewer and 
even more toxic. If HAART is delayed for too long, significant immune recovery 
may not occur32. The number of CD4-positive T-lymphocytes increases, but the 
function of these cells may be diminished. The patient is at higher risk of 
developing adverse reactions and immune reconstitution illnesses33 34. There is 
also the concern that they are at higher risk for developing cancer in the long-
term.  
 
2.2.2 South African controversies and stigma 
 
The management of the epidemic in South Africa has attracted global interest35. 
Some political leaders have denied that HIV infection results in AIDS36, in stark 
contrast to evidence from international literature. HAART has only been in use in 
South Africa for the past few years, despite it being well accepted in other 
countries since the 1990’s25 37. This delayed rollout of essential drug therapy has 
occurred as a result of a lack of political will in accepting the role that this therapy 
 18
plays, in favour of more traditional and dietary regimens which have not enjoyed 
acceptance elsewhere38. Now that HAART is available, the rollout continues to be 
hampered by administration and resource failings39. In 2005, only 30 000 HIV-
positive people had accessed HAART, out of approximately 1 650 000 HIV-
positive people meeting the criteria for commencement of therapy40.  
 
A further complication arises from the ongoing stigma attached to the HIV 
infection41. Poor education, mixed messages from government, and 
misinformation from community leaders has resulted in groups of people who 
refuse to believe in the existence of the infection, and subsequently refuse 
testing42. People are afraid to admit their HIV status, even after extensive 
counselling, which naturally leads to ongoing viral transmission and delayed 
access to healthcare services in the face of failing health. Principles expounded 
by education campaigns (for example condom use, faithfulness to a single 
partner and sexual abstinence43) are slow to be accepted. In addition, women are 
not empowered to make choices, or to insist on their partners changing their 
behaviour18. With the rollout of HAART, patients accessing treatment have often 
not informed family members of their status, and often have infected family 
members and spouses that refuse testing, even in the face of successful 
management42. Following on from these reasons, many people accessing 
healthcare are unaware of their HIV status and are reluctant to have their blood 
tested.  
 
At hospital level, a person can only be tested for HIV if they have given informed 
consent. This involves comprehensive counselling before the test is taken (pre-
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test counselling) and also after the result has been given (post-test counselling)3. 
This time-consuming process often requires trained counsellors, which is a 
limiting factor in performing research into HIV prevalence in smaller, more specific 
population groups – research which would help delineate which sections of the 
population carry high levels of disease burden.  
 
2.3   Preoperative assessment for anaesthesia 
 
2.3.1 The perioperative environment 
 
Anaesthetists work in the operating theatre environment, and as such are quite 
removed from what happens in the ward and in the community. Surgeons will 
book an operating list the previous day, and as a result the anaesthetist will have 
a limited period of time in which to assess the patient’s condition before surgery.  
 
This preoperative assessment is crucial to ensuring safe delivery of anaesthesia. 
The patient is interviewed and examined, in order to determine the level of risk 
associated with the ensuing anaesthetic. This short period of time is the only 
window of opportunity that the anaesthetist has to ascertain whether the patient 
has any special needs, or any areas in which there is cause for increased 
concern. Eliciting as much accurate information as possible will guide the 
anaesthetist in their decision making, in terms of type of anaesthetic chosen, 
drugs used, monitors required, possible complications to prepare for, as well as 
the nature of post-operative care necessary to arrange for the patient. 
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2.3.2 Use of the ASA physical status classification 
 
The American Society of Anaesthesiologists (ASA) physical status classification 
(Table 2.2) is used to grade patients in terms of the possibility of perioperative 
problems as a result of preoperative physical status44. Patients with chronic 
diseases tend to have a higher score assigned to them, depending on their level 
of disease control and the impact the disease has on their daily functioning. This 
scoring system has been widely in use since its original reporting in 1941, and 
subsequent modification in 196145. It has been criticised for being subjective46 47, 
as well as not accounting for multiple pathologies, however it has been shown 
repeatedly to correlate with perioperative mortality and morbidity48-51.  
 
Table 2.2   ASA physical status grading44 
 
ASA 
Physical 
Status 
Grading 
Description Expected 
perioperative 
mortality rate 
1 A normal, healthy patient. 0.06-0.08% 
2 A patient with mild systemic disease and 
no functional limitations. 
0.27-0.4% 
3 A patient with moderate to severe systemic 
disease that results in some function 
limitation. 
1.8-4.3% 
4 A patient with severe systemic disease that 
is a constant threat to life and functionally 
incapacitating. 
7.8-23% 
5 A moribund patient who is not expected to 
survive 24 hours with or without surgery. 
9.4-51 % 
E Indicates ‘emergency’.  
 
This correlation, as well as the ease with which it is used, has meant that, despite 
its faults, it is a score accepted by many anaesthetists who use it every day to 
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guide their decision-making in terms of investigating patients preoperatively. ASA 
1 and 2 patients are seldom investigated further following the interview and 
examination, as they are deemed essentially healthy with minimal functional 
limitation. ASA 3, 4 and 5 patients are often subject to extensive investigation 
prior to surgery, so that the exact degree of functional curtailment can be 
determined and possibly optimised in order to improve the outcome for the 
patient. In addition, they may be more intensively monitored intraoperatively.  
 
Hence it is clear that being able to accurately distinguish between ASA 1 and 2 
patients and ASA 3, 4 and 5 patients is of paramount importance if this scoring 
system is to be used (as it often is) to determine  preoperative and intraoperative 
management plans. 
 
2.3.3 Pitfalls in the use of the ASA physical status classification 
 
The shortfall of this system occurs in two situations. Firstly, an ASA 3 patient may 
be investigated unnecessarily, incurring cost, inconvenience and possible 
discomfort for poorly founded reasons. The results of the investigations may have 
no impact of further management of the patient. Secondly, an ASA 1 or 2 patient 
may not be investigated at all, thus running the risk of having vital information not 
being diagnosed. This latter scenario is of interest – we rely on interview 
technique and clinical acumen to determine whether a patient is healthy or not, 
and if deemed healthy, nothing further is done. Comorbidities that are subclinical 
are thus potentially undetected, with the assumption that if the comorbid entity is 
not causing clinical disease or functional limitation, it is not worth investigating.  
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2.3.4 Ordering special investigations 
 
After the initial interview and examination, the anaesthetist may choose to order 
blood tests, x-rays, cardiology or respiratory assessments or other investigations. 
The purpose of these is to aid the anaesthetist in ensuring perioperative safety for 
the patient. Typical examples are determinations of the initial haemoglobin 
concentration in a patient awaiting a total hip replacement, or having an 
electrocardiogram (ECG) done in order to determine the presence of ischaemic 
heart disease in a diabetic patient with poor effort tolerance.  
 
Previously, patients would be ‘tested routinely’, and all patients having surgery 
would often come to theatre armed with blood results, a chest x-ray and an ECG. 
This practice is expensive and unnecessary, and has thus fallen away52-54. The 
ASA set up a task force to help formalise this, and also produced a set of 
guidelines2. From this, investigations were suggested to be appropriate if they 
fulfilled one of three criteria (although not only limited to these):  
1. The discovery of a disease or disorder that may affect perioperative 
anaesthetic care. 
2. The verification or assessment of an already known disease, disorder, 
medical or alternative therapy that may affect perioperative anaesthetic 
care. 
3. The formulation of specific plans and alternatives for perioperative 
anaesthetic care. 
As a consequence, it has been left up to the individual anaesthetist to decide 
what is appropriate for an individual patient. Seemingly healthy patients seldom 
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require further investigation. However, patients with various comorbid conditions 
and clinical features of systemic disease will be subject to further testing in order 
to determine whether they will be able to endure anaesthesia and surgery, as well 
as to plan which anaesthetic and surgical technique will be the most appropriate 
for them. 
 
Investigations should only be requested if the results will have an impact on the 
management of the patient. Detecting a low preoperative haemoglobin level in a 
patient is deemed appropriate if there is an expectation of blood loss during the 
surgery so that the necessary blood products are ordered. Checking the platelet 
count in a pre-eclamptic parturient will guide the anaesthetist in terms of selecting 
the more commonly employed neuraxial anaesthetic technique or general 
anaesthesia, which is safer in patients with bleeding diatheses55. Decisions 
regarding proceeding with surgery can also be made based on judicious use of 
investigations. A patient with ischaemic heart disease and a strongly positive 
cardiac stress test may be referred for a coronary revascularisation procedure 
rather than proceeding with the planned elective surgical procedure56. If HIV 
infection is subclinical, it may only be detected if the patient’s blood is sent for 
testing. If this is not done, there may be some important implications. These are 
discussed later in this report. 
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2.3.5 Concerns with the extrapolation of guidelines 
 
Understandably, all these recommendations come from experience with patients 
with a wide range of common conditions. Panels of experts compile guidelines 
which individual practitioners then extrapolate (within reason) to apply to a 
specific clinical situation2 56. This method of practising is not without fault. 
Different populations display different burdens of disease, and guidelines created 
in the developed world may not always be applicable in developing countries. HIV 
infection is an example here - developed countries have prevalence rates that are 
generally low19. As a result, the presence or absence of HIV infection in a patient 
is seldom used to direct guidelines regarding clinical practice. It is debatable 
whether such guidelines can be used blindly in a population that is vastly 
different, such as in South Africa where the prevalence rate of HIV infection is 
high. 
 
2.4    Implications of the natural history of HIV infection on perioperative     
 management 
 
An HIV-positive person is one who has undergone seroconversion following 
exposure to HIV. The initial acute process may have clinical manifestations which 
are usually non-specific and transient, but it is most often asymptomatic. This is 
followed by a period of clinical latency, which can last from several months to 
several years. During this time, the immune system of the infected person 
gradually declines, as viral replication occurs at the expense of CD4-positive T-
lymphocytes. Eventually, this depletion results in clinical manifestations of 
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immune compromise, which start as non-specific signs and progress to the more 
well-known features of the Acquired Immune Deficiency Syndrome (AIDS)3 57. 
This is illustrated in Figure 2.1. 
 
 
 
Figure 2.1  The relationship of CD4-count and viral load over time in HIV  
  infection58 
 
The World Health Organisation (WHO) clinical staging system is used in South 
Africa59 (Table 2.1).   
 
Having looked at all this, making a diagnosis of HIV infection purely on clinical 
grounds is difficult. Early features of infection are usually ignored or dismissed as 
insignificant, and the latent period is asymptomatic. The rate of progression from 
infection to AIDS is based on a number of factors, and is often impossible to 
predict. Many infected people are clinically well for long periods of time despite 
severe immune compromise. Monitoring the CD4-count of HIV-positive people is 
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the most widely used screening method of assessing prognosis and assigning 
risk of clinical disease.  
 
Using the model wherein clinically well patients are not investigated 
preoperatively, patients that are asymptomatic and are as such deemed ‘clinically 
well’ may indeed be harbouring HIV infection. This would go undetected if no 
investigations were performed. This may not be a problem in its own right. Many 
anaesthetists would argue that HIV infection alone is not a reason to change the 
management plan of the patient. However, not detecting HIV infection may well 
prove to be problematic in the group of patients that are asymptomatic despite 
having significant degrees of immune compromise; for example the group of 
patients who most likely will begin to develop features of AIDS within the next few 
months. 
 
2.5   The immune system and the operating environment 
 
2.5.1  Anaesthesia and the immune system 
 
The implications of anaesthetising immune compromised patients are not fully 
elucidated. Reproducible evidence shows how anaesthesia in itself suppresses 
immunity60 61, in the context of lowering the typical physiological response to 
surgery. It has been suggested that anaesthesia alone causes a transient 
response62. However, the effects of the combination of surgery and anaesthesia 
on the level of immunity of a patient are indisputable63 64.  
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Different anaesthetic agents and different anaesthetic techniques have different 
effects on the immune system. Inhalational anaesthesia has been compared with 
intravenous as well as neurolept anaesthesia65. Different induction agents have 
been compared with each other, and the use of regional techniques has been 
looked at. The use of a propofol infusion as total intravenous anaesthesia (TIVA) 
has been shown to have less deleterious effect that balanced inhalational 
anaesthesia66 67. Propofol has been shown to be the safest induction agent68. 
Sevoflurane may have properties that alleviate the immunosuppressive effects of 
thiopentone and nitrous oxide69. Fentanyl has also been shown to have effects on 
immunity, raising the question of the safety of opioid-based anaesthesia70. Short-
acting opiates are safer than longer-acting morphine. The use of epidural 
analgesia postoperatively has also been shown to minimise the immune insult71. 
 
This knowledge can easily be compiled, and, with further research, anaesthetists 
could develop ‘immune-friendly’ techniques. These could be put to good use in a 
patient known to be HIV-positive (and thus heavily reliant on what remains of their 
immune function), especially when the CD4-count is low, or is unknown.  
 
2.5.2 Surgery and the immune system 
 
The surgical literature has explored the implications of operating on markedly 
immune compromised patients. A patient who presents with immune compromise 
before being operated on is clearly at a higher risk for poor postoperative immune 
function60 72-74. This results in an even higher risk for postoperative complications, 
especially in a resource-limited setting75-82. It appears prudent to find and employ 
 28
methods to boost the immune system before embarking on surgery. With the 
advent of HAART, surgeons have been looking at whether attempts should be 
made to raise the CD4-count in HIV-positive patients before operating83-85 on 
them . Orthopaedic surgeons have shown the greatest interest in this, as the 
development of sepsis around implantable foreign material carries grave 
implications86-89. Surgeons have suggested that raising the CD4-count to above 
200 cells.mm-3 before undergoing elective surgery would be beneficial to the 
patient, although this remains to be definitively proven. Some surgeons even go 
so far as to delay surgery until the CD4-count is above 500 cells.mm-3 90. 
 
While delaying surgery in order to initiate HAART may be appropriate in some 
instances, the advent of HAART has had other implications as well. Previously, 
HIV infection was an absolute contra-indication to patient selection for some 
procedures, such as organ transplantation. With HAART, HIV infection is being 
viewed more as a chronic disease than a preterminal condition, and HIV-positive 
people are starting to be considered for procedures such as solid organ 
transplantation and cardiac surgery91-95. Research has also shown that HIV-
positive patients with viral control on HAART have the same prognosis as HIV-
negative patients in the critical care setting. Thus, HIV-positive patients are no 
longer denied admission to the Critical Care Unit on the basis of their HIV status 
alone96. Diagnosing HIV infection can thus change the management of many 
patients.  
 
Surgical techniques are constantly being modified. The development of minimally 
invasive techniques has resulted in a greater awareness of the effect that surgery 
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has on the whole body. Laparoscopic techniques have been compared with open 
techniques, and have been consistently shown to cause a lesser degree of 
immune compromise97-101. Endovascular procedures have been shown to have 
similar effects102-105. Some cardiac surgery can be performed ‘off-pump’, thus 
avoiding the immune compromise associated with cardiopulmonary bypass106. 
These newer methods have been shown to decrease the length of hospital stay, 
decrease cost (after the initial outlay for equipment), and shorten the time taken 
for recovery in the majority of patients107.  
 
Some endoscopic and endovascular procedures can be performed under 
conscious sedation, or a light level of anaesthesia using a mask. Postoperatively, 
the fluid shifts seen after traditional open surgery are much less apparent, and the 
recovery of patients is  smoother and requires less nursing care. This is 
particularly relevant in the frail patient, as well as those with severe immune 
compromise and less organ function reserve as is seen in the patient with AIDS. 
 
2.5.3 Implications for postoperative recovery 
 
Both changes in surgical and anaesthetic technique could be employed in 
patients with low immunity in order to ensure swift uncomplicated postoperative 
recovery. Postoperative immune suppression puts a patient at a much higher risk 
of developing sepsis, a major cause of morbidity and mortality108. A large 
proportion of research into care of the critically ill involves finding methods to 
minimise the incidence of sepsis. Systemic sepsis and wound sepsis both result 
in compromised patient outcome, further postoperative complications, delayed 
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discharge and increased cost109. If severely immune compromised patients are 
currently recovering poorly, and thus requiring higher care facilities, then 
improved management strategies based on the preoperative detection of their 
disease may move forward in alleviating this problem. 
 
2.6   Further implications of the lack of knowledge of HIV status 
 
2.6.1 Public Health and access of healthcare 
 
The stigma associated with HIV infection in South Africa has already been 
discussed. Patients presenting for anaesthesia are usually unaware of their HIV 
status. Patients presenting for elective surgery are often clinically well, and as 
such would not be subject to preoperative investigations. These patients, having 
accessed healthcare for other reasons, namely the surgical pathology, would 
miss a potential screening opportunity which would enable access to the 
appropriate clinic to assess their HIV status and thus to initiate HAART.  
 
2.6.2 Opportunities for ongoing research 
 
There is very little literature available describing anaesthesia in HIV-positive 
patients. Most of the global HIV burden is carried by poorer developing 
countries110. Conversely, most significant research is conducted in wealthier 
developed countries, usually as a result of increased financial and human 
resources. Research into the effects that HIV has on anaesthesia (or vice versa) 
would require a sizeable database of HIV-positive patients presenting for 
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anaesthesia. This is unlikely in countries with a low disease burden, and in South 
Africa this is hampered by both the need for informed consent and counselling 
before testing and the lack of financial resources in the public sector. The 
information available regarding HIV and anaesthesia is largely expert opinion. 
Few clinical trials having been conducted, and there have been few randomised 
controlled trials published111-113.  
 
2.6.3 Implications for operating theatre staff safety 
 
Attention has been focussed on the dangers that blood-borne infections may 
pose on the anaesthetist, and on whether or not universal precautions for the 
prevention of transmission of blood-borne pathogens are adhered to in the 
operating theatre114. A list of these precautions is given in Table 2.3. Compliance 
is generally poor, but has been shown to increase if the patient in question is 
known to be HIV-positive115.  
Table 2.3 Universal precautions for the prevention of transmission of  
  blood-borne pathogens116 
Universal precautions for the prevention of transmission of blood-borne 
pathogens 
1. Take meticulous care to prevent injury when using, cleaning or disposing 
of sharp materials – needles, scalpels and other sharp instruments.  
2. Do not resheath needles, do not remove needles from syringes by hand, 
do not bend, break or otherwise manipulate needles by hand. 
3. Place used disposable syringes and needles, scalpel blades, suture 
needles or other sharp items in puncture-resistant containers. Keep the 
containers as close to the place of use as possible. 
4. Use protective barriers (gloves, eyeglasses, waterproof aprons and 
waterproof footwear) to prevent exposure to blood and body fluids. 
5. If hands or other skin surfaces are contaminated with blood or body fluids 
containing blood or other potentially infectious body fluids, wash 
immediately and thoroughly (as soon as patient safety permits). 
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2.7   Available literature and the need for further study 
 
The obstetric population has been investigated. Regional anaesthesia has been 
shown to be safe in HIV-positive mothers, and remains the treatment of choice117. 
Very little information is available about the effects that anaesthesia has on the 
HIV-positive patient in other settings. It is unclear whether surgery and 
anaesthesia affect the prognosis of the HIV-positive patient, or whether there are 
methods available to minimise any deleterious effects.  
 
Literature from the South African setting is even more scant. Guidelines regarding 
preoperative workup of patients do not include HIV status in their list of conditions 
to test for. No study has investigated the relationship between the level of 
immunity of a patient and the preoperative physical status associated. 
 
Estimating the prevalence in the patients presenting for anaesthesia is 
problematic. On the one hand, people coming to hospital are less healthy than 
the general population, so it would seem likely that the prevalence may be higher. 
On the other hand, patients are often only given the option of having elective 
surgery if they are indeed healthy, so the prevalence may be lower. In addition, a 
large proportion of patients present for emergency procedures, including trauma-
related, obstetric and gynaecological. Lastly, the population served by one 
department is specific to that hospital, both geographically and in terms of social 
demographics. All this contributes to the inhomogeneous nature of the sample in 
question. There has been no study determining the prevalence of HIV infection in 
patients presenting for anaesthesia in any Southern African context.  
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CHAPTER THREE - METHODOLOGY 
 
3.1   Study design 
 
The study was a prospective cross-sectional relational observational study. 
 
Prospective:  only individuals giving written informed consent will be 
included in the study. They will then be followed forward in time until the 
required data is collected. 
 
Cross-sectional:  data will be collected from participants at a single given 
 period. There will be no follow-up of participants following data collection. 
 
Relational:  part of the data will be analysed in order to determine the presence 
 or absence of a relationship between two subsets of the data. 
 
Observational:  the data will be collected without any intention of intervening 
 in any aspect of the management of the participants. 
 
This study design was chosen because it will provide an appropriate means of 
conducting a survey of the current status of patients presenting for anaesthesia at 
Chris Hani Baragwanath Hospital (CHBH). By accurately assessing the problems 
pertaining to the current practice of preoperative clinical assessment of patients, 
plans and policies can be made for future improvements in the management of 
patients. 
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3.2   Study site 
 
The study was conducted at Chris Hani Baragwanath Hospital (CHBH), in 
Soweto, Johannesburg. CHBH is a 2800-bed tertiary public hospital, which 
services a predominantly black population in the low-income bracket 
 
3.3   Study population 
 
The study population comprised all patients presenting for anaesthesia during the 
study period. 
 
3.4   Study period 
 
The study took place over a period of six weeks, from 1 December 2005 until 16 
January 2006. Permission to perform the study was granted by the Hospital Chief 
Executive Officer, and ethical clearance was granted by the Committee for 
Research on Human Subjects (Medical) of the University of the Witwatersrand 
(Appendix A). Four trained counsellors were employed for pre-test and post-test 
counselling, as well as to assist in referring the patient to the necessary 
healthcare providers as deemed appropriate. Patients signed the counselling 
form to confirm they had received appropriate pre-test counselling (Appendix F). 
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3.5   Sample population and sampling method 
In consultation with a biostatistician, a sample of 350 patients was selected. This 
number was chosen so that a two-sided 95% confidence interval for a single 
proportion (using the large sample normal approximation) would extend 0.05 
(setting significance at below 0.05) from the observed proportion for an expected 
proportion of 35%.  
Modified consecutive sampling was used. The hospital runs daily elective surgical 
lists from Monday to Friday, and has seven emergency theatres that run 24 hours 
a day. A daily list of all patients that were scheduled for anaesthesia was 
compiled, and all patients that had had emergency anaesthesia the day before 
was added to this list. A second list comprising every third patient on the first list 
was then drawn up, and these patients were approached for the purposes of the 
study. The selection processed stopped once 350 patients had been recruited.  
The hospital does cater for out-patient surgery, although the majority of patients 
spend at least one night in hospital before and one night after the surgery. These 
out-patients were also approached, if they had been included in the second list. 
They were given the option of waiting for their results or of coming back to the 
hospital at a later stage to get their results and post-test counselling. 
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3.6   Exclusion criteria 
 
The following patients were excluded from the study: 
1. Any patient under the age of 18 years, or otherwise unable to give 
informed consent. 
2. Any patient who refused to participate, after having received 
appropriate pre-test counselling, or chose to withdraw their name from 
the sample after they had already been tested. 
3. Any patient presenting for anaesthesia that was to be administered by 
someone other than an anaesthetist (for example procedures 
performed under local anaesthesia, procedures requiring conscious 
sedation administered by a nursing assistant) 
4. Any patient that had already been included in the study population (for 
example those patients coming for repeat surgery). 
 
3.7   Data collection 
 
Once the final list had been compiled, the patients were approached. The study 
was explained to them in a language that they could understand, by either the 
researcher or a translator. Patients received a written information sheet, detailing 
all aspects of the study. The information sheet was written in English (Appendix 
D).  
 
Patients were then given pre-test counselling by a trained counsellor. All 
explanations were done in a language that the patient could understand, in terms 
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of the National Health Act of 2003. Patients were allowed to withdraw their 
participation at any time, and at no time was a patient coerced into participation.   
 
If the patient consented (and signed the consent and counselling form – 
Appendix E and Appendix F), the patient was interviewed and examined. If the 
patient was previously proven to be HIV-negative, no blood samples were taken. 
The patient was required to show some sort of recent documentation of their HIV 
status in this instance. If the patient was known to be HIV-positive, a single blood 
sample was taken to be sent for a CD4-count. If the status of the patient was 
unknown, two blood samples were taken. The first sample was sent for Rapid HIV 
Antigen testing, using the Determine® HIV-1/2 rapid diagnostic test (Abbott 
Laboratories). This is a visually read, rapid immunochromatographic test for the 
detection of antibodies to HIV-1/2 in human serum, plasma and whole blood.  
This has a sensitivity of 99.9%, and a specificity of 97.8%, and is considered an 
acceptable test for use in clinical practice118. If this tested positive, the remainder 
of the specimen was sent for HIV ELISA testing, using an Elecsys 2010 HIV 
Combi® fourth generation HIV ELISA (Roche Diagnostics). This ELISA detects 
both HIV-1/2 antibodies and the p24 antigen, and is widely used as a 
confirmatory test for the presence of both early and established HIV infection. It 
has a 100% sensitivity and a 98.8% specificity119. If this confirmed the status of 
the patient to be HIV-positive, then the second sample was sent for CD4-count 
testing, using CD45-assisted pan-leucogating. This is an accurate, robust method 
of CD4 T-cell enumeration, and has been well validated120. These second 
samples were kept in appropriate laboratory conditions while waiting for the HIV 
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test results. If the first sample tested HIV-negative, the second sample was 
discarded.  
 
Once the HIV results were known, the counsellors approached the patients again 
and gave them their results, with the appropriate post-test counselling, unless the 
patient had requested not to know their HIV test result. The patients were referred 
to the appropriate healthcare facilities as necessary, for ongoing management of 
their condition, as well as ongoing counselling.  
 
Patient confidentiality was maintained at all times. Ward staff were not informed 
of the nature of the interviews, and results were not made available to anyone 
except the patients and their relevant counsellor. Patients were assigned a 
numerical code, and this was the only identifying feature on the data sheet. The 
codes were listed with the names and contact details of the patients on a 
separate sheet. This was kept locked away for the duration of the study, and 
remains available only to the researcher. The purpose of this list of details is to 
allow those patients that chose not to receive their results opportunity to change 
their mind in the future, because their results would not be available by any other 
method.  
 
Data capture was managed by entering values onto a separate page for each 
patient, as well as onto a spreadsheet. The details of the collected data are as 
follows: 
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1. Age – the patients were allocated to 1 of 5 randomly chosen age 
groups: 
i. 18-29 years 
ii. 30-39 years 
iii. 40-49 years 
iv. 50-59 years 
v. Over 60 years 
2. Gender (male or female) 
3. ASA physical status grading (from 1-5). The ‘E’ (denoting emergency) 
was omitted because the urgency of the procedure was noted 
separately. The specific guidelines used for patient classification in this 
study are tabulated in Table 3.1. Patients who were known to be HIV-
positive were not graded differently on the basis of this knowledge 
alone. The grade was only changed if the patient had clinical features 
of immune compromise, or if the patient was already taking HAART.  
4. Knowledge of HIV status (known or unknown) 
5. HIV status (positive or negative) 
6. CD4-count (in those that tested HIV-positive, or were known to be HIV-
positive) which was grouped into 1 of 5 groups. The following groups 
were chosen because they represented clinically significant categories 
(significance in brackets): 
i. 500 cells.mm-3 or more (normal) 
ii. 350-499 cells.mm-3 (still immune competent) 
iii. 200-349 cells.mm-3 (where initiation of HAART is 
considered in some countries) 
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iv. 50-199 cells.mm-3 (criterion for diagnosis of AIDS, and 
where initiation of HAART occurs in South Africa) 
v. Less than 50 cells.mm-3 (critically immune compromised, 
requiring fast-tracking of HAART) 
7. Management – whether those known to HIV-positive were taking 
HAART or not. 
8. Type of surgery – this was divided into obstetric surgery and non-
obstetric surgery.  
9. Urgency of surgery (elective or emergency), based on whether the 
procedure had been booked or an elective or an emergency list.  
10. Nature of surgery (clean or contaminated), based on whether the 
procedure had been booked on a list of clean or contaminated (septic) 
procedures. 
11. Time of day of surgery (office hours or after hours) – this only impacted 
on emergency procedures, as elective surgery was only done during 
office hours. This detail was chosen to try to determine whether more 
HIV-positive patients presented when anaesthetic staffing was at a 
minimum or not. If it were determined that there was a proven benefit to 
determining the HIV status of patients prior to surgery, this would 
increase the workload of staff (in terms of preoperative assessment, 
investigations and counselling), which would have greatest impact 
when staff numbers were lowest. 
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Table 3.1   HIV/AIDS-related criteria used in this study for classification  
  according to the ASA Physical Status Grading System  
 
ASA 
Physical  
Status 
Grading 
Examples of criteria used for categorisation 
1 Asymptomatic 
No previous long-term illnesses 
Clinically normal 
2 Persistent generalised lymphadenopathy 
Features of WHO clinical stage 2 
Past history of significant illness, eg pulmonary tuberculosis fully 
treated more than one year previously with no subsequent 
limitations of function 
Patients on HAART with full viral suppression 
3 Features of WHO clinical stage 3 
Still able to function in a limited capacity 
Patients on HAART with suboptimal viral suppression 
4 Features of WHO clinical stage 4 
Not expected to die within the next 24 hours 
5 Life-expectancy less than 24 hours 
(No patient in the study met this criteria) 
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Measures to minimise error were employed. Data was captured using double 
entries, that is, it was entered on two separate sheets which were checked 
against each other. The complete data set was checked by a biostatistician for 
errors and missing data.  
 
3.8    Data analysis 
 
The data were analysed using the Stata statistical software package. The 
association between the ASA physical status grading and HIV status as well as 
the CD4-count was determined using logistic regression modelling and the 
Mantel-Haenszel combined odds ratio (thus adjusting for confounding variables). 
Disease prevalence in each group was also determined by logistic regression 
modelling, and patient groups were compared using the Chi-squared test, 
Fisher’s exact test and the continuity correction. Statistical significance was set at 
p≤0.05.  
 
3.9   Funding 
 
The study was funded by means of a research grant from the Jan Pretorius Fund, 
provided by the South African Society of Anaesthesiologists. 
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CHAPTER FOUR – RESULTS 
 
4.1   Sample and patient refusal 
 
A total of 369 patients were approached. Nineteen patients (5.1%) refused to 
participate. Reasons for refusal included not wanting to have more blood taken in 
patients who had been in hospital for some time), fear of receiving the result, fear 
of not recovering from the surgery because of additional stress, and not feeling 
the need to have blood tested, on the basis of being sure of being HIV-negative 
(older patients and patients who were no longer sexually active).   
 
4.2   Prevalence in total sample 
 
In the total sample of 350 patients, 103 were confirmed to be HIV-positive, giving 
an overall prevalence of 29.4% (95% CI 24.9 – 34.4). 
 
4.3   Distribution of sample according to ASA physical status grading 
 
The total sample distribution according to ASA grade and HIV status is shown in 
Table 4.1. Patients classified as ASA 1 or 2 comprised 82.6% of the total sample. 
Of these, 31.8% were HIV-positive, and 68.2% were HIV-negative. Patients 
classified as ASA 3 or 4 comprised the remaining 17.4% of the sample, and of 
these, 18.0% were HIV-positive and 82.0% were HIV-negative.  
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Table 4.1 Distribution of sample according to ASA grade and HIV status 
 
 Total (%) HIV-positive (%) HIV-negative (%) 
ASA 1 or 2 289/350 (82.6) 92/289 (31.8) 197/289 (68.2) 
ASA 3 or 4 61/350 (17.4) 11/61 (18.0) 50/61 (82.0) 
 
Within the total sample, the classification of ASA grade was most affected by age, 
regardless of HIV status. Using logistic regression analysis, younger patients 
were more likely to be classified as ASA 1 or 2 than older patients (p<0.0001).  
 
Within the HIV-positive group, the likelihood of being classified as ASA 1 or 2 was 
analysed. Confounders were found to be the nature of surgery (clean or septic) 
and the urgency of surgery (elective or emergency). After adjusting for these, 
using the Mantel-Haenszel combined odds ratio, patients were more likely to be 
ASA 1 or 2. The adjusted odds ratio (OR) of 2.1 (p<0.05).  
 
4.4   Relationship between ASA physical status grading and CD4-count 
 
The distribution of data according to ASA grade and CD4-count in the HIV-
positive group is shown in Table 4.2. No patient met the criteria for classification 
as ASA 5. There were 92 HIV-positive patients who were classified as ASA 1 or 
2. Of these, 26.1% had a CD4-count of 500 cells.mm-3 or greater, 16.3% had a 
CD4-count of 350-499 cells.mm-3, 34.8% had a CD4-count of 200-349 cells.mm-3, 
19.6% had a CD4-count of 50-199 cells.mm-3, and 3.3% had a CD4-count below 
50 cells.mm-3. There were 11 HIV-positive patients who were classified as ASA 3 
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or 4. Of these, 2 patients had a CD4-count of 500 cells.mm-3 or greater, 3 patients 
had a CD4-count of 200-349 cells.mm-3, 3 patients had a CD4-count of 50-199 
cells.mm-3, and 3 patients had a CD4-count below 50 cells.mm-3. 
 
Table 4.2 Association between ASA physical status grading and CD4- 
  count in HIV-positive patients 
 
 ASA 1 or 2 (%) 
(n=92) (%) 
ASA 3 or 4  
(n=11) 
CD4-count 
(cells.mm-3) 
<50 3 (3.3) 3 
50-199 18 (19.6) 3 
200-349 32 (34.8) 3 
350-499 15 (16.3) 0 
500+ 24 (26.1) 2 
 
Patients were more likely to be ASA 1 or 2 if their CD4-count was above 200 
cells.mm-3 (crude OR 3.88, p<0.05). However, within the group of patients with 
CD4-counts below 200 cells.mm-3 (n=27), 21 patients (77.78%) were also 
classified as ASA 1 or 2, which represented a significant majority (p<0.0001). 
Moreover, there were 3 patients with a CD4-count of below 50 cells.mm-3 that 
were also classified as ASA 1 or 2. 
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4.5  Prevalence in different patient subgroups 
 
The prevalence of HIV in the different subgroups is summarised in Table 4.3.  
 
Table 4.3 Differences in HIV prevalence in different demographic   
  subgroups 
 
 HIV-POSITIVE/TOTAL (%) 
GENDER Male 29/142 (20.4) 
Female 74/208 (35.6) 
AGE (YEARS) 18-29 49/152 (32.2) 
30-39 34/79 (43.0) 
40-49 14/56 (25.0) 
50-59 4/37 (11.1) 
60+ 2/26 (7.7) 
TYPE OF SURGERY Obstetric 51/137 (37.2) 
Non-obstetric 52/213 (24.4) 
NATURE OF SURGERY Clean 87/300 (29.0) 
Septic 16/50 (32.0) 
URGENCY OF SURGERY Emergency 71/221 (32.1) 
Elective 32/129 (24.8) 
TIME OF DAY Office hours 65/215 (30.2) 
After hours 38/135 (28.1) 
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The male subgroup had an HIV prevalence of 20.4%, while the female subgroup 
had an HIV prevalence of 35.6%. Therefore, female patients had a higher 
prevalence of HIV than males (p<0.005). 
 
In the different age groups, 32.2% of patients aged 18-29 years were HIV-
positive, 43.0% of patients aged 30-39 years were HIV-positive, 25.0% of patients 
aged 40-49 years were HIV-positive, 11.1% of patients aged 50-59 years were 
HIV-positive, and 7.7% of patients aged 60 years and older were HIV-positive.  
 
Patients presenting for obstetric surgery had an HIV prevalence of 37.2%, while 
those presenting for non-obstetric surgery had an HIV prevalence of 24.4%. 
Therefore, patients undergoing obstetric procedures had a higher prevalence 
than those undergoing non-obstetric procedures (p<0.05). 
 
Patients presenting for clean procedures had an HIV prevalence of 29.0%, while 
those presenting for septic procedures had an HIV prevalence of 32.0%. This 
difference did not achieve statistical significance. 
 
Patients presenting for emergency surgery had an HIV prevalence of 32.1%, 
while those presenting for elective surgery had an HIV prevalence of 24.8%. This 
difference did not achieve statistical significance. 
 
The subgroup with the highest prevalence was patients aged 30-39 years 
(43.0%), and the lowest HIV prevalence was found in patients aged 60 years and 
older (7.7%). 
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4.6   Patient knowledge of HIV status and patients on HAART 
 
Only 103 patients (29.4%) were aware of their HIV status. Of these, 38 (36.9%) 
were HIV-positive, which represented 10.9% of the total sample. Only 4 patients 
in this group (10.5%) had been started on HAART – this represented 3.8% of the 
total HIV-positive group. This was despite the fact that although 11 patients 
(28.9% of the group that knew they were HIV-positive) met the criteria for 
initiation of HAART (on the basis of having a CD4-count below 200 cells.mm-3). 
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CHAPTER FIVE - DISCUSSION 
 
5.1    The problem of patient refusal 
 
Some difficulties were encountered while collecting the data for this study. Patient 
refusal was known to be a possibility, and as shown, 5.1% of patients approached 
refused to participate. This is not a high proportion of the total, and considering 
that the patients who refused were from different groups and refused for different 
reasons, it is unlikely to have had much impact on the validity of the results. 
Patient refusal was for both reasons that may have indicated that they were at 
high risk for testing HIV-positive, and for reasons that suggested that they were 
low risk for testing HIV-positive. The worst scenario would have been if all those 
that refused had been HIV-positive – this would have increased the total 
prevalence from 29.4% to 33.1%. If all 19 had tested HIV-negative, the overall 
prevalence would have dropped from 29.4% to 22.8%.  
 
5.2     Potential biases in this study 
 
5.2.1 Study period 
 
The data collection was done over a six-week period in December and January. 
Some elective lists are closed for one or two weeks during this period. The 
patients presenting during this time could have been scheduled for more 
emergent procedures than at other times of the year. Some of the elective 
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theatres may have been used for procedures normally booked in emergency 
theatres. 
 
5.2.2 Patient categorisation 
 
Patients were categorised on the basis of the type of operating theatre in which 
they were booked, whether clean or contaminated, elective or emergent. In most 
instances, this can be assumed to be a reasonable way of deducing the nature 
and urgency of the planned procedure. However there may have been times 
when this did not hold true.  
 
The theatres used for clean surgery are all scrubbed down at the end of the day, 
and as a result some surgeons occasionally take the opportunity of adding 
contaminated cases onto the end of a clean list. Similarly, it may happen that an 
emergency case is done on an elective list if the delay for the emergency theatre 
is too long, or if the elective list has been completed earlier than expected.  
 
Patients are booked on emergency lists at the hospital for all manners of 
procedures, and with varying level of urgency. The categorisation of patients as 
‘emergency’ in this study thus simply denotes that the patients were most likely to 
have been seen by the anaesthetist for the first time outside theatre, with no 
opportunity to investigate the patient further or suggest alternative management 
strategies. This may not always have been true – patients presenting for elective 
caesarean sections are booked on the same list as those for emergency 
caesarean sections, and patients presenting for elective termination of 
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pregnancies are booked on the same list as those presenting for uterine 
evacuation for unexpected and incomplete miscarriages. These elective patients 
on emergency lists are still not seen before they arrive in theatre. It is very seldom 
that any further work-up is requested before operating. They are, however, kept 
starved, unlike many other emergency cases.  
 
5.2.3   Quality of data collection 
 
This was a single observer study. There was assistance for some of the data 
collection, however only the researcher was involved in the decision-making 
process. The ASA physical status grading is quite a subjective classification – this 
bias was thus minimised by the fact that only one person (the researcher) 
decided which grade a patient was assigned. This fact on its own, however, is 
another source for bias – the researcher may have been stricter or more lenient in 
grading patients than other anaesthetists. A list of inclusion criteria for each 
grading (tabulated previously – see Table 3.1) was referred to in order to 
minimise this. 
 
5.2.4   Contextuality 
 
The study was conducted at CHBH, a large tertiary state hospital servicing a 
population of predominantly low-income black patients from Soweto and 
surrounding areas, in Johannesburg. It may not be possible to generalise the 
results of this study to other population groups. 
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5.3   Clinical evaluation in HIV 
 
Distributing the sample across different ASA grades yielded interesting results. 
Younger patients were more likely to be classified as ASA 1 or 2 than older 
patients, regardless of HIV status. This showed that age is a much more 
significant variable in predicting ‘wellness’ than any other variable studied. Within 
the HIV-positive group, the nature of surgery (clean or contaminated) was 
discovered to be a confounder, which is expected. Patients presenting with 
localised or systemic sepsis are certainly more likely to be more ill than those 
presenting to the clean theatres. The urgency of surgery was also found to be a 
confounder. Reasons for this are less clear, as many emergency cases are still 
graded as ASA 1 or 2. Possible reasons could be the high burden of septic 
emergencies that present to the hospital, or the ages of patients presenting to the 
emergency theatres. The latter reason is less likely, in view of the high caseload 
of trauma and obstetric emergencies seen at the hospital – these usually involve 
younger patients. After adjusting for these confounders, HIV-positive patients 
were still more likely to be classified as ASA 1 or 2 (adjusted odds ratio OR 2.1). 
In other words, more HIV-positive patients presenting for theatre will appear well 
than those appearing unwell. 
 
As has already been discussed, HIV infection remains asymptomatic for a varying 
length of time, with many infected individuals only manifesting clinical features 
once they have reached a significant level of immune compromise. This was 
supported by the findings in the study population. Patients grouped as ASA 1 or 2 
were frequently found to have low CD4-counts. More than half (57.6%) had CD4-
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counts below 350 cells.mm-3, and 22.8% met the National Criteria for initiation of 
HAART (CD4-count below 200 cells.mm-3). As expected, patients with higher 
CD4-counts were more likely to be classified as ASA 1 or 2 than those with lower 
CD4-counts (crude OR 3.88). However, what was interesting was that even within 
the group of patients with CD4-counts below 200 cells.mm-3, 77.78% of patients 
were still classified as ASA 1 or 2. This is a significant majority. There were even 
patients with CD4-counts below 50 cells.mm-3 who met the same criteria – all 
appearing well with a normal functional capacity, despite clear laboratory 
evidence of significant immune compromise. These patients are unlikely to have 
been tested for HIV on clinical grounds alone, and as such their underlying 
deficiency would have certainly been missed. 
 
These results were found despite the potential for bias, because of a single 
observer classifying patients into ASA physical status grades, where the observer 
specifically looked out for AIDS-related signs. In the non-research environment, 
patients presenting for emergency procedures may not be examined as 
thoroughly as those presenting electively, and the more subtle signs of immune 
compromise may be missed. In this study, patients with clinical features of 
significant immune compromise were usually graded as ASA 3 or 4 (based on 
their functional capacity). 
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5.4  Prevalence and high-risk groups 
 
The total prevalence found in the sample population is higher than that of the 
general population. It is more in line with the figures generated by the 
seroprevalence studies of women attending antenatal clinics. This helps to show 
the heterogeneity of the population that present for anaesthesia.  
 
Clearly, women are more at risk than men of testing HIV-positive. This is shown 
by the prevalence differences between female and male patients (35.6% 
compared to 20.4%). It is further illustrated by the differences between patients 
presenting for different types of surgery: 35.9% in patients presenting for obstetric 
and gynaecological procedures, compared to 25.0% in patients presenting for 
other types of surgery. This is in keeping with national statistics, where female 
gender has consistently been shown to be a factor for increased risk of infection.  
 
Differences in prevalence between the different age groups are also in keeping 
with what has been found in previous studies. The highest prevalence has always 
been found to be in those of reproductive age, or from 25-35 years of age. In this 
study, the highest prevalence of all was in patients aged 30-39 years (43.0%). 
The older groups had the lowest prevalence, with those patients aged 60 years 
and older being at the lowest risk (7.7%).  
 
Patients presenting for contaminated procedures were at no significantly higher 
risk for testing HIV-positive than those presenting for clean procedures (32.0% 
compared with 29.0%). This could emphasise just how many patients who were 
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HIV-positive were indeed asymptomatic. HIV-positive patients are at higher risk 
for septic complications if they are more severely immune compromised, so if 
more HIV-positive patients in the sample had been clinically unwell on the basis 
of their HIV infection, this difference might have been greater.  
 
Patients presenting for emergency procedures had slightly increased likelihood of 
testing HIV-positive than those presenting for elective procedures (32.1% 
compared with 24.8%), although this also did not achieve significance. If this 
result was borne out in a larger sample, it may show that healthier patients are 
selected for elective surgery, and that the larger proportion of the HIV infection 
burden is carried by those who do not present in time for preoperative workup. In 
the future, it may become definitively clear that HIV-positive patients would 
benefit from initiation on HAART before having some types of surgery. This result 
shows that there would still need to be practices in place in which to manage an 
HIV-positive patient who has not yet been started on HAART. 
 
Investigating the time of day of patient presentation also yielded no significant 
differences. Of patients presenting for anaesthesia during office hours, 30.2% 
tested HIV-positive, compared with 28.1% of those who presented after hours. 
This means that if it is shown to be of benefit to test patients prior to having 
anaesthesia, then there will be a need for an after-hours laboratory service. At 
CHBH, a 24-hour emergency laboratory is equipped with facilities for Rapid HIV 
Antibody testing. In addition, most hospitals are staffed by the minimum number 
of healthcare providers after hours. Testing at this time would then only be 
feasible if it were simple to do, requiring the minimum number of people. 
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Adequate counselling facilities are usually not available. The protocols drawn up 
for HIV-testing would need to be revised in order to address this problem, 
perhaps allowing for testing to be done anonymously before surgical intention, 
and allowing the patient to receive the required counselling and result on the 
following day.  
 
The groups shown to be at a higher risk for HIV infection are identified based on 
comparison with the groups with lower prevalence. However, it is clear that all 
groups are at a higher risk for HIV infection when compared with the rest of the 
world. The lowest prevalence shown (7.7%) is already significantly higher than 
the prevalence in other research populations. If it is shown that testing patients 
preoperatively would result in a change of anaesthetic practice which would 
benefit the patient, this would imply that all patients at CHBH would benefit from 
this, not only those in the higher risk groups. 
 
5.5   Knowledge of HIV status 
 
If a significant proportion of patients had been found to already know their HIV 
status (whether HIV-positive or HIV-negative), preoperative HIV testing would be 
less of a pressing issue. The anaesthetist could select a management plan based 
purely on the history taken from the patient. However, only 29.4% of the patients 
studied knew their status. In the group that knew, 36.9% were HIV-positive, and 
28.9% of these met the criteria for initiation of HAART. However, only 4 of the 
HIV-positive patients in the study (3.8%) had been started on the therapy by the 
time they presented for anaesthesia.  
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All women attending antenatal clinic are offered HIV testing. This was initiated so 
that HIV-positive mothers could be given nevirapine, an antiretroviral drug used to 
help prevent mother-to-child transmission of HIV. The drug is given to the mother 
approximately four hours before delivery of the infant, and then a second dose is 
given to the infant the following day. Subsequently, the majority of patients 
presenting for anaesthesia for obstetric procedures knew their status. Very few of 
them had had a CD4-count taken though, and some of them were found to have 
marked immune suppression. The emphasis in the management of these women 
appears to be more towards stopping the transmission of HIV to the infant, and 
less towards the maintenance of good health in the mother. Pregnant women are 
tested quite late in their pregnancy, and most of the patients presenting for 
obstetric procedures in early pregnancy did not know their HIV status. 
 
Some patients that knew their status had only recently been tested, during their 
current admission. This was done for several reasons. Patients sometimes 
request testing, or are tested at the suggestion of the healthcare provider. HIV-
positive patients from this group occasionally knew their CD4-counts as well, 
which had been taken after their status had been confirmed. Patients are seldom 
started on HAART while they are admitted for acute illnesses, especially those 
not related to HIV infection. The knowledge of their status could have been used 
to formulate the safest management plan (both anaesthetic and surgical) for 
them.  
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5.6   Concerns regarding preoperative HIV testing 
 
One of the primary concerns for embarking on preoperative testing of any sort is 
the potential for harm. As with any decision, the benefits of testing need to be 
weighed against the associated risks.  
 
The actual testing process is not considered to be harmful, as it involves simple 
blood sampling. This is much more of a concern in children, where painful 
procedures are kept to a minimum. The delay of waiting for test results is also 
unlikely to be much of a concern, as the Rapid Antigen test can be completed in 
15 minutes. If this short delay is too long, then the planned procedure is likely to 
be of such an emergent nature as to preclude many options available for 
anaesthesia in any event. In this case, the benefit of the HIV result would be less 
evident. 
 
The implications associated with the HIV test results are more of a cause for 
concern. The stigma associated with HIV infection, as well as a general lack of 
education regarding the options available for the management of the infection, 
have already resulted in too few people volunteering to find out their status. This 
problem has improved slightly with the roll-out of HAART in South Africa, however 
it remains a hurdle.  
 
The spread of HIV in South Africa is largely by sexual transmission, and this 
social element to the disease often gives rise to feelings of guilt, as well as 
assigning blame to a sexual partner. Patients may react to a positive test result in 
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varying ways, for example with denial, anger, fear or depression. For this reason, 
results should only be given once the patient has been adequately counselled. 
This is possible in the elective situation, but becomes problematic prior to more 
urgent procedures. If adequate counselling is not provided before operating, then 
the patient should only receive their test results once the procedure is completed. 
Patients are often anxious before surgery. Postoperative disclosure would also 
prevent additional preoperative anxiety resulting from the possibility of a positive 
test result. 
 
The stigma associated with HIV may not be confined to patients only. Healthcare 
providers may also show stigma, which may not be based on scientific evidence. 
The roll-out of HAART has affected the medical disciplines more than the surgical 
ones, and surgeons and anaesthetists may not be well versed in the 
management of patients taking unfamiliar drugs. Knowing that a patient is HIV-
positive may trigger the unnecessary cancelling of procedures, or the presumed 
need for additional investigations or specialist referrals. Adopting more regular 
preoperative HIV testing should therefore be undertaken with this in mind, and 
theatre staff education should become a priority.  
 
5.7  Potential benefits of preoperative HIV testing 
 
Knowing the HIV status of a patient before operating can have many benefits. 
The primary benefit is that the management of the patient could be altered in a 
way that would result in the best outcome. Surgery and anaesthesia both result in 
immune suppression, which is exacerbated by pre-existing immune compromise. 
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An HIV-positive patient with significant preoperative immune compromise could 
be considered for initiation of HAART, with the option to delay elective surgery 
until there is some degree of return of immune function.  
 
There are often instances where the risks of starting HAART or delaying surgery 
are greater than the benefit that this return of immunity would confer. In these 
cases, the type of surgery planned could be changed – for example, to a 
minimally invasive technique, and the mode of anaesthesia could be tailored. An 
anaesthetist may choose to anaesthetise the patient using total intravenous 
anaesthesia (TIVA) by means of a propofol infusion, which may confer less of an 
insult to the immunity of the patient, or they may choose to insert an epidural 
catheter for intra- and postoperative analgesia. The patient may be considered for 
postoperative recovery in a high-care setting where this would not have been 
considered otherwise. 
 
There are other benefits to preoperative HIV testing, which may be secondary to 
the primary concern of the patient in question, but nevertheless warrant attention.  
 
The South African public sector is a resource-limited environment. Research, 
which often requires considerable funding, is given much less of a priority than 
service delivery. Subsequently, healthcare providers are often forced to rely on 
evidence obtained in very different settings, which cannot always be appropriately 
extrapolated to the South African hospital setting. There is very little data 
available regarding HIV and anaesthesia in general, and even less pertaining 
specifically to South African healthcare. Determining the HIV status of patients 
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presenting for anaesthesia would provide an invaluable resource in terms of 
further study into safer anaesthesia. This benefit could be carried over into the 
realm of critical care as well as pain management. Epidemiological studies could 
also be facilitated. 
 
There is also a potential benefit from a Public Health perspective. In a setting 
where the disease prevalence in the general population is high, any access to 
healthcare should be seen as an opportunity to screen for HIV. Earlier education 
and intervention regarding regular follow-up, 6-monthly CD4-counts, counselling, 
diet and lifestyle changes is preferable at all stages of HIV infection. The timely 
introduction of HAART is far superior to starting therapy later, as has been 
discussed. 
 
Lastly, the operating theatre is a high-risk area for disease transmission to all 
healthcare workers. While it is prudent to comply with universal precautions 
regardless of the disease profile of the patient, compliance has been shown to 
increase if the patient is known to be HIV-positive. This knowledge may also 
encourage the development of more ergonomic methods to ensure compliance 
with universal precautions. This is often not seen as needing high priority in a 
resource-limited setting.  
 
5.8   Preoperative testing and other diseases with high prevalence 
 
Guidelines drawn up by professional and expert bodies play a large role in 
ensuring safe anaesthetic practice. However, it is important to use these 
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guidelines in the most appropriate way for the population in question. Healthy 
individuals presenting for surgery may not need any form of preoperative testing, 
but in a setting where there is a high prevalence of a disease which may not be 
clinically manifest, this disease should be screened for, if it has the potential to 
change perioperative management.  
 
5.9   Further research 
 
There are many unanswered questions regarding HIV and safe anaesthetic 
practice.  
 
The trials investigating different anaesthetic techniques and their effects on the 
immune system should be repeated in HIV-positive patients. HIV-positive patients 
with varying levels of immune compromise should be studied in terms of the 
effect of anaesthesia and surgery on their individual immune systems.   
 
Long-term effects of anaesthesia and surgery on the natural history and 
prognosis of HIV infection should be determined, and the results in patients not 
taking HAART should be compared with those taking HAART. 
 
Cost-effectiveness studies should be conducted in the setting in which 
widespread HIV testing will be taking place. 
 
The effects of anaesthesia on HIV-positive patients taking HAART should be 
evaluated, in order to determine whether there is any change in their response to 
 63
the therapy. Research into the safety of anaesthetising a patient taking HAART 
should also be conducted. This information should be used in conjunction with 
surgical findings in order to determine the benefits and risks of delaying surgery in 
HIV-positive patients in order to initiate HAART.  
 
The attitudes of patients and healthcare providers to the results of an HIV test 
should be investigated. This could help determine the effect that stigma and lack 
of education would have on patient care should HIV testing be made a more 
frequent preoperative investigation. 
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CHAPTER SIX – SUMMARY AND CONCLUSIONS 
 
6.1    Summary 
 
The majority of HIV-positive patients in the sample were classified as ASA 1 or 2, 
in other words, essentially asymptomatic with no clinical signs. A significant 
proportion of these had markedly low CD4-counts, signifying considerable 
immune compromise. This shows that HIV infection and the ensuing immune 
compromise cannot be reliably diagnosed on clinical grounds alone.  
 
Patients presenting for anaesthesia at Chris Hani Baragwanath Hospital have a 
high prevalence of HIV infection. Groups at higher risk for infection are females, 
patients presenting for obstetric procedures, and patients in younger age groups. 
However, all patients are a significantly higher risk for infection than those from 
population groups in other parts of the world.  
 
Most patients did not know their HIV status. Very few of the HIV-positive patients, 
including those that knew their status, had been started on HAART. 
 
6.2    Conclusions 
 
The results of this study bring into question the manner in which HIV-positive 
patients presenting for anaesthesia are managed. Preoperative HIV testing at 
CHBH should be encouraged, because it has been shown that HIV infection is 
often not detected clinically. Patients that test HIV-positive should be further 
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investigated as to their level of immunity, as this is also not always clinically 
apparent. The high prevalence of HIV at CHBH emphasises that this should be 
made a priority. 
 
Sufficient evidence exists to suggest that there are numerous ways in which we 
could minimise the immune insult created by surgery and anaesthesia. These 
practices could be applied to HIV-positive patients, especially those with a 
significant degree of immune compromise. Knowing the HIV status of patients will 
provide a means for anaesthetists and surgeons to formulate and adopt more 
appropriate management plans which would directly benefit the patient.  
 
HIV-positive patients could be referred to the appropriate facility for management 
of their condition, and the initiation of HAART if necessary. Presentation for 
anaesthesia and surgery should be seen as a vital opportunity for accessing 
healthcare, and holistic patient management would be facilitated. 
 
Further research into improved management plans for HIV-positive patients 
presenting for anaesthesia could be conducted. More widespread testing for HIV 
infection would facilitate sampling for such studies. 
 
The safety of operating theatre staff should also be prioritised, in view of the high 
prevalence of HIV infection in the patients arriving in theatre. Accessible, feasible 
protocols could be developed for the ease of implementation of universal 
precautions in theatre, in order to minimise accidental exposure to HIV infection. 
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APPENDIX D Patient information sheet 
 
INFORMATION SHEET 
 
Good morning/afternoon. My name is Dr Penfold. I am a registrar in the 
Department of Anaesthesia of this hospital. 
 
You are going to have an operation that is going to require an anaesthetic. I am 
doing a study on all patients that receive anaesthetics in this hospital, and I would 
like to invite you to be a part of this study. 
 
Firstly, have you ever heard of HIV or AIDS ? 
 
HIV is an infection that is common in South Africa. It is spread in body fluids, so 
people can be infected during sexual intercourse, sometimes a pregnant mother 
can give it to her unborn child, and people can get it from some forms of contact 
with contaminated blood. 
 
HIV is a virus, in other words a germ. It attacks the body’s ability to fight other 
germs. Over time, a person infected with HIV becomes unable to fight infection 
caused by germs that would not normally make a person sick. At this stage, we 
say the person has AIDS. 
 
At the moment, there is no cure for HIV or AIDS. However, there are some 
medicines available that can slow down the progress of the disease. The 
treatment cannot get rid of the HIV in the patient, but it can help to get them back 
to the stage where they are not as sick as they were before. These medicines are 
available for free at this hospital. 
 
I am doing a study to find out how many patients receiving anaesthetics are HIV-
positive, and how many have AIDS. I also want to see how unwell the patients 
with HIV and AIDS look, to see if we can see that they have the virus without 
testing for it. In order to find this out, I need to test every patient coming for an 
anaesthetic for HIV. I want to make it clear that I have no reason to suspect that 
you either HIV-positive or HIV-negative, I simply want to test everyone. 
 
The results of this study will show how many patients coming for operations 
should be receiving the medicine that helps to fight HIV. This will help these 
patients know that they need to go to the clinic where the treatment is given. It will 
also help us to know we need to do more studies to see if we are treating these 
patients in the safest way for them. We may start to test more people for HIV, 
based on these results – especially if the patients that are found to be HIV-
positive look so well that we don’t suspect HIV in them. 
 
If you agree to be part of my study, I will send a trained counsellor to come and 
talk to you about what it means to have an HIV test. If you still agree to be tested, 
I will come and take two tubes of blood from you – about two teaspoons full. This 
will require an injection, which can be painful. 
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The first tube will be tested for HIV using the quick test that we use. If the quick 
test shows that the blood is HIV-positive, the rest of that tube will be sent for 
another HIV test that will double-check the result. If the second test also shows 
that the blood is HIV-positive, then I will send the second tube for a test called a 
CD4-count. This test helps to show how far the HIV infection has progressed. If it 
is a very low number, then it means that the HIV has killed a lot of cells that help 
to fight infection, and it might mean that you will need to go on treatment. 
 
If the quick test shows that the blood is HIV-negative, then we won’t need to 
double check, and the second tube of blood will be thrown away.  
 
All the results will be kept confidentially – only I will know the results. Not even 
your name will be kept with the results – I will keep your name and contact 
number on a separate paper, in case you want to get hold of me. The results will 
be kept under a secret code.  
 
I will also look at your hospital file to get some more information about you. I will 
need to write down your age, sex, what type of operation you are going for, how 
urgent your operation is, whether your operation is clean or septic, and what time 
of day you are going to have your operation. I will also ask you some questions 
about your general state of health, and I will examine you to see how healthy you 
are. 
 
You can choose whether you would like to receive your results or not. If you 
choose to receive your results, a counsellor will come again to give you the 
results as well as more information to help you with the results. You can also 
choose to receive your results at a later stage. Test results take about two days to 
be ready. 
 
If you do not agree to be part of the study, this is absolutely fine. The care you 
receive in the hospital will not change at all, and I will fully accept your decision. If 
you agree to be part of the study but then you change your mind later, you can 
contact me and I will immediately remove all information about you out of the 
study.  
 
If you agree to be part of the study, I will need you to sign a form stating that I 
have explained the study well, and that you understand how you will be involved. 
I will also need you to sign another form after you have received counselling, to 
say that you have been fully counselled. 
 
Do you have any questions to ask me ? 
 
If you have any questions at a later stage, or if you want to contact me for 
anything regarding the study, you can contact me at any time of the day at 082 
771 8296. 
 
Thank you for giving up your time to hear about the study. 
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APPENDIX E Informed consent form 
 
 
 
 
 
 
 
I, ________________________________________, agree to participate in the 
study that Dr Penfold has explained to me. 
 
I understand that I will have counselling, then I will have two tubes of blood taken 
from me. One tube will be tested for HIV, and if the blood is HIV-positive, then the 
other tube will be sent for a CD4-count. 
 
I understand that I can choose whether or not to receive my test results. My 
results will be kept confidentially, and my name will not be kept with my results. I 
will receive counselling if I choose to receive my results. 
 
I understand that Dr Penfold will take some information from my file – my age and 
sex, and information about the operation I am going to have: what type of 
operation it is, how urgent it is, whether it is clean or septic, and what time of day I 
am going to have the operation. 
 
I understand that Dr Penfold is going to ask me questions about my general 
health, and that she is going to examine me. 
 
I understand that I can choose to pull out of the study at any time, and I have Dr 
Penfold’s contact number. 
 
 
 
 
 
___________________________         ____________________________ 
Signature     Date 
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APPENDIX F Counselling form  
 
 
 
 
 
 
 
I, _____________________________________, have received pre-test 
counselling as part of my agreement to participate in Dr Penfold’s study. 
 
 
 
 
¨ I would like to receive my test results, and I have made arrangements 
with my counsellor to meet for post-test counselling 
 
 
 
¨ I would not like to receive my test results at this stage. If I change my 
mind in the future, I know that I can contact Dr Penfold at any time to 
arrange to receive my results with post-test counselling. 
 
 
 
 
 
 
_______________________________   
Signature of patient 
 
 
 
 
 
 
_______________________________  
Signature of counsellor 
 
 
 
 
 
_______________________________  
Date 
 
